Stock THEMISMED THEMIS MEDICARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Themis Medicare Limited NSE India S.E.

Equities

THEMISMED

INE083B01024

Pharmaceuticals

Delayed NSE India S.E.
Other stock markets
 06:01:53 2024-06-27 am EDT 		5-day change 1st Jan Change
209.8 INR -2.23% Intraday chart for Themis Medicare Limited -5.28% -1.84%
May. 14 Themis Medicare Limited Recommends Dividend for Financial Year Ended March 31, 2024, Payable on or after July 22, 2024 CI
May. 14 Themis Medicare Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization 1 2,722 2,205 2,575 8,585 10,735 20,157
Enterprise Value (EV) 1 3,562 3,225 3,263 9,180 11,533 21,016
P/E ratio -25.3 x 8.9 x 7.22 x 11.8 x 18.9 x 46.4 x
Yield - 0.73% 1.53% 0.54% 0.43% 0.23%
Capitalization / Revenue 1.48 x 1.09 x 1.12 x 2.18 x 3.03 x 5.28 x
EV / Revenue 1.94 x 1.6 x 1.41 x 2.33 x 3.25 x 5.5 x
EV / EBITDA 156 x 9.13 x 6.68 x 9.69 x 17.3 x 41.2 x
EV / FCF -106 x -12.8 x 14.7 x 651 x -46.8 x -288 x
FCF Yield -0.95% -7.79% 6.82% 0.15% -2.14% -0.35%
Price to Book 1.72 x 1.2 x 1.18 x 2.99 x 3.16 x 5.34 x
Nbr of stocks (in thousands) 91,809 91,880 91,880 92,003 92,028 92,040
Reference price 2 29.64 24.00 28.03 93.32 116.6 219.0
Announcement Date 8/1/19 9/6/20 8/25/21 8/26/22 8/16/23 6/25/24
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net sales 1 1,838 2,016 2,307 3,946 3,543 3,818
EBITDA 1 22.79 353.4 488.8 947.1 666.9 510.5
EBIT 1 -57.11 273.8 409.5 861.6 569.6 392.6
Operating Margin -3.11% 13.58% 17.75% 21.83% 16.07% 10.28%
Earnings before Tax (EBT) 1 -126 268.7 413.3 952.6 725.1 534.4
Net income 1 -107.4 247.8 357 728.8 569 435.2
Net margin -5.85% 12.29% 15.48% 18.47% 16.06% 11.4%
EPS 2 -1.170 2.697 3.884 7.907 6.173 4.720
Free Cash Flow 1 -33.72 -251.1 222.5 14.11 -246.5 -72.97
FCF margin -1.84% -12.46% 9.64% 0.36% -6.96% -1.91%
FCF Conversion (EBITDA) - - 45.51% 1.49% - -
FCF Conversion (Net income) - - 62.31% 1.94% - -
Dividend per Share - 0.1750 0.4300 0.5000 0.5000 0.5000
Announcement Date 8/1/19 9/6/20 8/25/21 8/26/22 8/16/23 6/25/24
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt 1 840 1,020 688 595 798 859
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 36.85 x 2.886 x 1.408 x 0.6278 x 1.197 x 1.682 x
Free Cash Flow 1 -33.7 -251 222 14.1 -246 -73
ROE (net income / shareholders' equity) -6.58% 14.5% 17.8% 28.8% 18.2% 12.1%
ROA (Net income/ Total Assets) -1.15% 5.16% 7.1% 13.5% 7.56% 4.54%
Assets 1 9,320 4,807 5,030 5,407 7,527 9,582
Book Value Per Share 2 17.20 19.90 23.80 31.20 36.90 41.00
Cash Flow per Share 2 0.1900 0.3600 2.070 2.200 1.360 1.080
Capex 1 56.3 58.1 180 206 287 184
Capex / Sales 3.07% 2.88% 7.82% 5.23% 8.11% 4.82%
Announcement Date 8/1/19 9/6/20 8/25/21 8/26/22 8/16/23 6/25/24
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.39% 43.67B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+26.21% 22.79B
SANDOZ GROUP AG Stock Sandoz Group AG
+20.99% 15.45B
CIPLA LIMITED Stock Cipla Limited
+18.82% 14.29B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+53.37% 12.83B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-11.88% 6.52B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+12.62% 5.59B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. THEMISMED Stock
  4. THEMISMED Stock
  5. Financials Themis Medicare Limited